Comments
Loading...
Portage Biotech (PRTG) Forecast
NewsEarningsPortage Biotech (PRTG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPortage Biotech (NASDAQ:PRTG) Stock Quotes, Forecast and News Summary
Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Portage Biotech (PRTG) stock?
You can purchase shares of Portage Biotech (NASDAQ:PRTG) through any online brokerage.
Who are Portage Biotech (PRTG) competitors?
Other companies in Portage Biotech’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and Viracta Therapeutics (NASDAQ:VIRX).
What is the forecast, or price target, for Portage Biotech (PRTG) stock?
Portage Biotech has a consensus price target of $14.50.
What is the current price for Portage Biotech (PRTG)?
The stock price for Portage Biotech (NASDAQ: PRTG) is $4.6549 last updated November 21, 2024 at 9:53 AM EST.
Does Portage Biotech (PRTG) pay a dividend?
There are no upcoming dividends for Portage Biotech.
When is Portage Biotech (NASDAQ:PRTG) reporting earnings?
Portage Biotech’s Q2 earnings are confirmed for Tuesday, December 3, 2024.
Is Portage Biotech (PRTG) going to split?
There is no upcoming split for Portage Biotech.
What sector and industry does Portage Biotech (PRTG) operate in?
Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.